1
|
Boksha IS, Lunin VG, Danilova TA, Poponova MS, Polyakov NB, Lyashchuk AM, Konstantinova SV, Galushkina ZM, Ustenko EV. Recombinant Endopeptidases IdeS and IdeZ and Their Potential Application. Biochemistry (Mosc) 2023; 88:731-740. [PMID: 37748870 DOI: 10.1134/s0006297923060020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 04/14/2023] [Accepted: 04/15/2023] [Indexed: 09/27/2023]
Abstract
Endopeptidases IdeS and IdeZ (streptococcal virulence factors that specifically cleave IgG heavy chains) are of particular interest because of their potential use in biotechnology, medicine, and veterinary. Genes encoding these enzymes were cloned and expressed in Escherichia coli heterologous expression system (ideS was cloned from a Streptococcus pyogenes collection strain; ideZ from Streptococcus zooepidemicus was synthesized). The 6His-tag was introduced into the amino acid sequence of each endopeptidase, and IdeS and IdeZ were purified by metal affinity chromatography to an apparent homogeneity (according to polyacrylamide gel electrophoresis). Purified enzymes were active against human and animal IgGs; their specificity toward human IgGs was confirmed by polyacrylamide gel electrophoresis. Recombinant IdeZ was used for immunological analysis of equine strangles infection (diagnostics and determination of the titer of specific antibodies in blood). Hence, IdeZ can be used in veterinary and sanitary microbiology to diagnose infections caused by Streptococcus equi and S. zooepidemicus in addition to its application in medicine and biotechnology.
Collapse
Affiliation(s)
- Irina S Boksha
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
- Mental Health Research Centre, Moscow, 115522, Russia
| | - Vladimir G Lunin
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Tatyana A Danilova
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Maria S Poponova
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Nikita B Polyakov
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Alexander M Lyashchuk
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Svetlana V Konstantinova
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Zoya M Galushkina
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Ekaterina V Ustenko
- Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| |
Collapse
|
2
|
Egorova DA, Solovyev AI, Polyakov NB, Danilova KV, Scherbakova AA, Kravtsov IN, Dmitrieva MA, Rykova VS, Tutykhina IL, Romanova YM, Gintsburg AL. Biofilm matrix proteome of clinical strain of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unit. Microb Pathog 2022; 170:105714. [PMID: 35973647 DOI: 10.1016/j.micpath.2022.105714] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Revised: 05/30/2022] [Accepted: 08/04/2022] [Indexed: 10/15/2022]
Abstract
Extracellular matrix plays a pivotal role in biofilm biology and proposed as a potential target for therapeutics development. As matrix is responsible for some extracellular functions and influence bacterial cytotoxicity against eukaryotic cells, it must have unique protein composition. P. aeruginosa is one of the most important pathogens with emerging antibiotic resistance, but only a few studies were devoted to matrix proteomes and there are no studies describing matrix proteome for any clinical isolates except reference strains PAO1 and ATCC27853. Here we report the first biofilm matrix proteome of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unit. We have identified the largest number of proteins in the matrix among all published studies devoted to P. aeruginosa biofilms. Comparison of matrix proteome with proteome from embedded cells let us to identify several enriched bioprocess groups. Bioprocess groups with the largest number of overrepresented in matrix proteins were oxidation-reduction processes, proteolysis, and transmembrane transport. The top three represented in matrix bioprocesses concerning the size of the GO annotated database were cell redox homeostasis, nucleoside metabolism, and fatty acid synthesis. Finally, we discuss the obtained data in a prism of antibiofilm therapeutics development.
Collapse
Affiliation(s)
- Daria A Egorova
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1).
| | - Andrey I Solovyev
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Nikita B Polyakov
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Ksenya V Danilova
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Anastasya A Scherbakova
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Ivan N Kravtsov
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Maria A Dmitrieva
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Valentina S Rykova
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Irina L Tutykhina
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1)
| | - Yulia M Romanova
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1); I.M. Sechenov First Moscow State Medical University, Moscow, 119992, Russia(2)
| | - Alexander L Gintsburg
- National Research Center of Epidemiology and Microbiology n. a. N.F. Gamaleya, Russian Ministry of Health, Moscow, 123098, Russia(1); I.M. Sechenov First Moscow State Medical University, Moscow, 119992, Russia(2)
| |
Collapse
|
3
|
Danilova TA, Danilina GA, Adzhieva AA, Polyakov NB, Zhukhovitskii VG. Antibacterial Activity of Lactobacillus plantarum Supernatant on Non-Fermenting Gram-Negative Bacteria. Bull Exp Biol Med 2022; 173:59-62. [PMID: 35622249 DOI: 10.1007/s10517-022-05493-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Indexed: 10/18/2022]
Abstract
We studied the effect of the L. plantarum strain supernatant on the growth of culture and biofilm of non-fermenting bacteria of the genera Pseudomonas, Achromobacter, and Burkholderia. To obtain a supernatant, the culture of L. plantarum was grown for 48 h at 37°C on a Lactic broth nutrient medium with casein peptone, then centrifuged and filtered through a 0.22-μm Millipore filter. Antimicrobial activity was determined by broth microdilution assay. The inhibitory effect of the supernatant on the growth of bacteria of all three genera was demonstrated. The maximum inhibition was observed for P. aeruginosa (by 13 times compared to the control). For bacteria of the Achromobacter and Burkholderia genera, the inhibition was less pronounced: by 7 and 6 times, respectively. The supernatant also inhibited biofilm formation by P. aeruginosa and A. ruhlandii, but did not affect formed biofilm. Thus, the L. plantarum supernatant obtained by us exhibited pronounced antimicrobial activity against non-fermenting bacteria, the causative agents of nosocomial infections, especially in immunocompromised individuals, very often in cystic fibrosis patients.
Collapse
Affiliation(s)
- T A Danilova
- Laboratory of Indication and Ultrastructural Analysis of Microorganisms, N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.
| | - G A Danilina
- Laboratory of Indication and Ultrastructural Analysis of Microorganisms, N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A A Adzhieva
- Laboratory of Indication and Ultrastructural Analysis of Microorganisms, N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - N B Polyakov
- Laboratory of Indication and Ultrastructural Analysis of Microorganisms, N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V G Zhukhovitskii
- Laboratory of Indication and Ultrastructural Analysis of Microorganisms, N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
4
|
Karyagina AS, Gromov AV, Grunina TM, Lyaschuk AM, Grishin AV, Strukova NV, Generalova MS, Galushkina ZM, Soboleva LA, Dobrinina OY, Bolshakova TN, Subbotina ME, Romanovskaya-Romanko EA, Krasilnikov IV, Polyakov NB, Solovyev AI, Grumov DA, Zhukhovitsky VG, Ryabova EI, Prokofiev VV, Lunin VG. Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19. Biochemistry Moscow 2021; 86:1275-1287. [PMID: 34903153 PMCID: PMC8527442 DOI: 10.1134/s0006297921100096] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A new platform for creating anti-coronavirus epitope vaccines has been developed. Two loop-like epitopes with lengths of 22 and 42 amino acid residues were selected from the receptor-binding motif of the Spike protein from the SARS‑CoV‑2 virus that participate in a large number of protein-protein interactions in the complexes with ACE2 and neutralizing antibodies. Two types of hybrid proteins, including one of the two selected epitopes, were constructed. To fix conformation of the selected epitopes, an approach using protein scaffolds was used. The homologue of Rop protein from the Escherichia coli ColE1 plasmid containing helix-turn-helix motif was used as an epitope scaffold for the convergence of C- and N-termini of the loop-like epitopes. Loop epitopes were inserted into the turn region. The conformation was additionally fixed by a disulfide bond formed between the cysteine residues present within the epitopes. For the purpose of multimerization, either aldolase from Thermotogamaritima, which forms a trimer in solution, or alpha-helical trimerizer of the Spike protein from SARS‑CoV‑2, was attached to the epitopes incorporated into the Rop-like protein. To enable purification on the heparin-containing sorbents, a short fragment from the heparin-binding hemagglutinin of Mycobacterium tuberculosis was inserted at the C-terminus of the hybrid proteins. All the obtained proteins demonstrated high level of immunogenicity after triplicate parenteral administration to mice. Sera from the mice immunized with both aldolase-based hybrid proteins and the Spike protein SARS‑CoV‑2 trimerizer-based protein with a longer epitope interacted with both the inactivated SARS‑CoV‑2 virus and the Spike protein receptor-binding domain at high titers.
Collapse
Affiliation(s)
- Anna S Karyagina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
- All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia
- Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia
| | - Alexander V Gromov
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Tatyana M Grunina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
- All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia
| | - Alexander M Lyaschuk
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Alexander V Grishin
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Natalia V Strukova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Maria S Generalova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Zoya M Galushkina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Lyubov' A Soboleva
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Olga Yu Dobrinina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Tatyana N Bolshakova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Marina E Subbotina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
- All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia
| | | | - Igor V Krasilnikov
- Saint Petersburg Institute of Vaccines and Sera, FMBA, St. Petersburg, 198320, Russia
| | - Nikita B Polyakov
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
- Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia
| | - Andrey I Solovyev
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Daniil A Grumov
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Vladimir G Zhukhovitsky
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Ekaterina I Ryabova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Vladimir V Prokofiev
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Vladimir G Lunin
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
- All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia
| |
Collapse
|
5
|
Egorova DA, Voronina OL, Solovyev AI, Kunda MS, Aksenova EI, Ryzhova NN, Danilova KV, Rykova VS, Scherbakova AA, Semenov AN, Polyakov NB, Grumov DA, Shevlyagina NV, Dolzhikova IV, Romanova YM, Gintsburg AL. Integrated into Environmental Biofilm Chromobacterium vaccinii Survives Winter with Support of Bacterial Community. Microorganisms 2020; 8:microorganisms8111696. [PMID: 33143246 PMCID: PMC7716238 DOI: 10.3390/microorganisms8111696] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Revised: 09/30/2020] [Accepted: 10/29/2020] [Indexed: 12/27/2022] Open
Abstract
Chromobacterium species are common in tropical and subtropical zones in environmental samples according to numerous studies. Here, we describe an environmental case of resident Chromobacterium vaccinii in biofilms associated with Carex spp. roots in Moscow region, Russia (warm-summer humid continental climate zone). We performed broad characterization of individual properties as well as surrounding context for better understanding of the premise of C. vaccinii survival during the winter season. Genome properties of isolated strains propose some insights into adaptation to habit and biofilm mode of life, including social cheaters carrying ΔluxR mutation. Isolated C. vaccinii differs from previously described strains in some biochemical properties and some basic characteristics like fatty acid composition as well as unique genome features. Despite potential to modulate membrane fluidity and presence of several genes responsible for cold shock response, isolated C. vaccinii did not survive during exposure to 4 °C, while in the complex biofilm sample, it was safely preserved for at least half a year in vitro at 4 °C. The surrounding bacterial community within the same biofilm with C. vaccinii represented a series of psychrophilic bacterial species, which may share resistance to low temperatures with other species within biofilm and provide C. vaccinii an opportunity to survive during the cold winter season.
Collapse
Affiliation(s)
- Daria A. Egorova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
- Correspondence: (D.A.E.); (O.L.V.); Tel.: +7-985-312-53-30 (D.A.E.); +7-916-224-86-83 (O.L.V.)
| | - Olga L. Voronina
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
- Correspondence: (D.A.E.); (O.L.V.); Tel.: +7-985-312-53-30 (D.A.E.); +7-916-224-86-83 (O.L.V.)
| | - Andrey I. Solovyev
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Marina S. Kunda
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Ekaterina I. Aksenova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Natalia N. Ryzhova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Ksenya V. Danilova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Valentina S. Rykova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Anastasya A. Scherbakova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Andrey N. Semenov
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Nikita B. Polyakov
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
- Vernadsky Institute of Geochemistry and Analytical Chemistry of Russian Academy of Sciences, 119991 Moscow, Russia
| | - Daniil A. Grumov
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Natalia V. Shevlyagina
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Inna V. Dolzhikova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
| | - Yulia M. Romanova
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
- Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119991 Moscow, Russia
| | - Alexander L. Gintsburg
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health, 123098 Moscow, Russia; (A.I.S.); (M.S.K.); (E.I.A.); (N.N.R.); (K.V.D.); (V.S.R.); (A.A.S.); (A.N.S.); (N.B.P.); (D.A.G.); (N.V.S.); (I.V.D.); (Y.M.R.); (A.L.G.)
- Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119991 Moscow, Russia
| |
Collapse
|
6
|
Karpov DS, Osipova PG, Domashin AI, Polyakov NB, Solovyev AI, Zubasheva MV, Zhukhovitsky VG, Karpov VL, Poddubko SV, Novikova ND. [Hyper-Resistance of the Bacillus licheniformis 24 Strain to Oxidative Stress Is Associated with Overexpression of Enzymatic Antioxidant System Genes]. Mol Biol (Mosk) 2020; 54:858-871. [PMID: 33009795 DOI: 10.31857/s0026898420050043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Accepted: 05/15/2020] [Indexed: 11/24/2022]
Abstract
At the International Space Station (ISS), artificial living conditions are created and maintained to satisfy human needs, these conditions are also favorable for the growth of numerous microorganisms, molds and bacteria. Among the microorganisms detected on the ISS are those from the automicroflora of crew members, and a significant number of spore-forming bacteria. In most cases, this group of microorganisms gives rise to strains that are able to colonize, grow and reproduce on interior materials and equipment of stations, and may be involved in biodestructive processes. These bacteria show increased resistance to various stress factors, for example, DNA-damaging and oxidizing agents. The molecular mechanisms of this resistance to stress are poorly understood. As part of the sanitary-microbiological monitoring of the ISS habitat, the Bacillus licheniformis 24 strain was isolated. Here, we demonstrated that this strain has increased resistance to hydrogen peroxide and Paraquat when compared to the "terrestrial" B. licheniformis B-10956 strain. B. licheniformis 24 overexpressed genes encoding enzymes that neutralize reactive oxygen species, such as KatX catalase and the superoxide dismutases SodA and SodF. Apart from this, in comparison with B. licheniformis B-10956, of B. licheniformis 24 cells had lower hydrogen sulfide production that was associated with sharply reduced expression of the cysIJ operon that encodes sulfite reductase. The results indicate that enzymatic antioxidant protective systems make a more significant contribution to the hyper-resistance of Bacillus strains to oxidizing agents than components of non-enzymatic systems, such as hydrogen sulfide.
Collapse
Affiliation(s)
- D S Karpov
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.,
| | - P G Osipova
- State Scientific Center of the Russian Federation, Institute of Bio-Medical Problems, Russian Academy of Sciences, Moscow, 123007 Russia
| | - A I Domashin
- State Scientific Center of the Russian Federation, Institute of Bio-Medical Problems, Russian Academy of Sciences, Moscow, 123007 Russia
| | - N B Polyakov
- Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098 Russia.,Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119334 Russia
| | - A I Solovyev
- Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098 Russia
| | - M V Zubasheva
- Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098 Russia
| | - V G Zhukhovitsky
- Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098 Russia.,Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119991 Russia
| | - V L Karpov
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia
| | - S V Poddubko
- State Scientific Center of the Russian Federation, Institute of Bio-Medical Problems, Russian Academy of Sciences, Moscow, 123007 Russia
| | - N D Novikova
- State Scientific Center of the Russian Federation, Institute of Bio-Medical Problems, Russian Academy of Sciences, Moscow, 123007 Russia
| |
Collapse
|
7
|
Karyagina AS, Grunina TM, Poponova MS, Orlova PA, Manskikh VN, Demidenko AV, Strukova NV, Manukhina MS, Nikitin KE, Lyaschuk AM, Galushkina ZM, Cherepushkin SA, Polyakov NB, Solovyev AI, Zhukhovitsky VG, Tretyak DA, Boksha IS, Gromov AV, Lunin VG. Synthesis in Escherichia coli and Characterization of Human Recombinant Erythropoietin with Additional Heparin-Binding Domain. Biochemistry (Mosc) 2018; 83:1207-1221. [PMID: 30472958 DOI: 10.1134/s0006297918100061] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Recombinant human erythropoietin (EPO) with additional N-terminal heparin-binding protein domain (HBD) from bone morphogenetic protein 2 was synthesized in Escherichia coli cells. A procedure for HBD-EPO purification and refolding was developed for obtaining highly-purified HBD-EPO. The structure of recombinant HBD-EPO was close to that of the native EPO protein. HBD-EPO contained two disulfide bonds, as shown by MALDI-TOF mass spectrometry. The protein demonstrated in vitro biological activity in the proliferation of human erythroleukemia TF-1 cell test and in vivo activity in animal models. HBD-EPO increased the number of reticulocytes in the blood after subcutaneous injection and displayed local angiogenic activity after subcutaneous implantation of demineralized bone matrix (DBM) discs with immobilized HBD-EPO. We developed a quantitative sandwich ELISA method for measuring HBD-EPO concentration in solution using rabbit polyclonal serum and commercial monoclonal anti-EPO antibodies. Pharmacokinetic properties of HBD-EPO were typical for bacterially produced EPO. Under physiological conditions, HBD-EPO can reversibly bind to DBM, which is often used as an osteoplastic material for treatment of bone pathologies. The data on HBD-EPO binding to DBM and local angiogenic activity of this protein give hope for successful application of HBD-EPO immobilized on DBM in experiments on bone regeneration.
Collapse
Affiliation(s)
- A S Karyagina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. .,All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.,Belozersky Institute of Physical and Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia
| | - T M Grunina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - M S Poponova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - P A Orlova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - V N Manskikh
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.,Belozersky Institute of Physical and Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia
| | - A V Demidenko
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - N V Strukova
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - M S Manukhina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - K E Nikitin
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - A M Lyaschuk
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - Z M Galushkina
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - S A Cherepushkin
- State Research Institute of Genetics and Selection of Industrial Microorganisms, Kurchatov Institute National Research Centre, Moscow, 117545, Russia
| | - N B Polyakov
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.,Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119334, Russia
| | - A I Solovyev
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - V G Zhukhovitsky
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia
| | - D A Tretyak
- Moscow Technological University (Lomonosov Institute of Fine Chemical Technologies), Moscow, 119571, Russia
| | - I S Boksha
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.,Research Center of Mental Health, Moscow, 115522, Russia
| | - A V Gromov
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
| | - V G Lunin
- Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.,All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia
| |
Collapse
|
8
|
Polyakov NB, Slizhikova DK, Izmalkova MY, Cherepanova NI, Kazakov VS, Rogova MA, Zhukova NA, Alexeev DG, Bazaleev NA, Skripnikov AY, Govorun VM. Proteome analysis of chloroplasts from the moss Physcomitrella patens (Hedw.) B.S.G. Biochemistry (Mosc) 2011; 75:1470-83. [PMID: 21314618 DOI: 10.1134/s0006297910120084] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Intact chloroplasts were prepared from protoplasts of the moss Physcomitrella patens according to an especially developed method. They were additionally separated into stroma and thylakoid fractions. The proteomes of intact plastids, stroma, and thylakoids were analyzed by 1D-electrophoresis under denaturing conditions followed by protein digestion and nano-LC-ESI-MS/MS of tryptic peptides from gel bands. A total of 624 unique proteins were identified, 434 of which were annotated as chloroplast resident proteins. The majority of proteins belonged to a photosynthetic group (21.3%) and to the group of proteins implicated in protein degradation, posttranslational modification, folding, and import (20.6%). Among proteins assigned to chloroplasts, the following groups are prominent combining proteins implicated in metabolism of: amino acids (6.9%), nucleotides (2.5%), lipids (2.2%), carbohydrates (2.4%), hormones (1.5%), isoprenoids (1.25%), vitamins and cofactors (1%), sulfur (1.25%), and nitrogen (1%); as well as proteins involved in the pentose-phosphate cycle (1.75%), tetrapyrrole synthesis (3.7%), and redox processes (3.6%). The data can be used in physiological and photobiological studies as well as in further studies of P. patens chloroplast proteome including structural and functional specifics of plant protein localization in organelles.
Collapse
Affiliation(s)
- N B Polyakov
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Batrakov SG, Rodionova TA, Esipov SE, Polyakov NB, Sheichenko VI, Shekhovtsova NV, Lukin SM, Panikov NS, Nikolaev YA. A novel lipopeptide, an inhibitor of bacterial adhesion, from the thermophilic and halotolerant subsurface Bacillus licheniformis strain 603. Biochim Biophys Acta Mol Cell Biol Lipids 2004; 1634:107-15. [PMID: 14643798 DOI: 10.1016/j.bbalip.2003.09.004] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
A new Bacillus licheniformis strain, 603, isolated from a mixture of drilling fluid and subsurface thermal water, has been found to produce a cyclic lipopeptide which is released into cultural medium as well as present in cells as the major lipid constituent (57% of the total cell lipids extractable with 2:1 chloroform-methanol). The quantitative ratio of the extracellular and intracellular lipopeptide has been estimated as 23:10. The metabolite represents a heptapeptide, L-Asp-->L-Leu-->L-Leu-->L-Val-->L-Val-->L-Glu-->L-Leu, N-acylated to the N-terminal amino acid, L-Asp, by a 3-hydroxy fatty acid (from 13:0 to 17:0 with n-, iso-, and anteiso-chains), the 3-OH group of which is esterified by the C-terminal amino acid, L-Leu. The chemical structure of the lipopeptide has been established by means of infrared (IR), 1H- and 13C-nuclear magnetic resonance (NMR) spectroscopy, electrospray ionisation (ESI) mass spectrometry (MS), including secondary ion mass spectrometry, along with chemical and enzymatic degradation. Although a diversity of similar metabolites synthesised by various B. licheniformis strains are presently known, such a structure has not been reported thus far. Added to the growth medium of strain 603 at the concentration of 1.6 microg/ml, the lipopeptide prevents adhesion of cells to a glass surface. Also, it exhibits a considerable growth-inhibiting activity against Corynebacterium variabilis and a much lower activity against Acinetobacter sp.
Collapse
Affiliation(s)
- Stanislav G Batrakov
- Russian Research Centre Hydrobios of Ministry of Health, ul. Kosmonavtov 18, korp. 2, Moscow 129301, Russia
| | | | | | | | | | | | | | | | | |
Collapse
|